The WHO approves lenacapavir every six months as a new step in HIV prevention, simplifying diagnoses and expanding ...

A Lancet study reports a 41-year-old man with advanced HIV carried COVID-19 for more than 750 days. Researchers warn ...

Treating obstructive sleep apnea in people living with HIV reduces fatigue and improves cardiovascular health, with similar ...

A man living with advanced HIV carried COVID-19 for more than 750 days. During the chronic infection, the virus mutated ...

Following on their singular, successful case report 2 of an infected infant started on ART 30 hours after birth, often referred to as the "Mississippi baby" in HIV literature, Deborah Persaud, MD, and ...

CBD may be a promising therapy for people living with HIV. While the virus can be controlled with treatment, it can still wreak havoc on the brain and cause problems with cognition. FIU researchers ...

Advances in HIV medication, its window of detection and its transmission risk within the last decade have led to an updated ...

Researchers at the German Center for Infection Research (DZIF) at Heidelberg University Hospital have decoded a previously ...

In patients with HIV infection, continuing or discontinuing abacavir in the dolutegravir/lamivudine combination is linked to ...